POAI

1 BTC

=

- USD

Predictive Oncology Inc. Common Stock logo

Predictive Oncology Inc. Common Stock

POAI🇺🇸
Coming Soon
0.00%

As of May 30, 2026 at 24:05 UTC

Chart

About Predictive Oncology Inc. Common Stock

Sector
ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES
Headquarters
PITTSBURGH
Employees (FY)
24
Listed
2010-05-03
FIGI
BBG000PVXTF7

Predictive Oncology Inc functions in the healthcare domain. The firm's reportable segments are Pittsburgh segment that provides services which include the application of AI using its proprietary biobank of 150,000+ tumor samples. It also creates proprietary 3D culture models used in drug development; Birmingham segment that provides contract services and research focused on solubility improvements, stability studies, and protein production; and Eagan segment that produces the FDA-cleared STREAMWAY System and associated products for automated medical fluid waste management and patient-to-drain medical fluid disposal. It derives maximum revenue from Eagan Segment.

Market Statistics

Market Capâ‚¿ 275.20
24h Volume-
24h Change0.00%
7d Change0.00%
1m Change0.00%

Trading Metrics

Trading Volume (BTC)-

How to Buy POAI

1

Create Your Account

Sign up, deposit BTC, and transfer it to your Unified Trading Account. It only takes a moment.

2

Start Your Trade

From Terminal, click Trade Now on the asset you want to buy. You'll be purchasing its tokenized asset.

3

Buy POAI

Enter the amount and confirm your purchase. That's it! You'll see the impact of the trade in your Unified Trading Account.

New to Tokenized Assets? Learn more in our Help Center.

Latest News

5 articles
GlobeNewswire Inc. favicon
GlobeNewswire Inc.www.globenewswire.com

Predictive Oncology raised $343.5 million through private placements to support a digital asset treasury strategy focused on Aethir's ATH token, aiming to enhance computational capabilities for AI-driven drug discovery.

Related:
Benzinga favicon
Benzingawww.benzinga.com

U.S. stocks traded higher with Nasdaq gaining 150 points. Pending home sales surged 4% in August, marking the sharpest gain in five months. Several biotech companies experienced significant stock price movements.

GlobeNewswire Inc. favicon
GlobeNewswire Inc.www.globenewswire.com

Predictive Oncology will implement a 1-for-15 reverse stock split on September 30, 2025, to maintain Nasdaq listing compliance by addressing minimum bid price requirements.

Related:
GlobeNewswire Inc. favicon
GlobeNewswire Inc.www.globenewswire.com

Predictive Oncology and Every Cure are collaborating to use AI platforms for identifying and repurposing existing drugs for cancer treatments, leveraging their respective AI technologies and extensive biobanks to accelerate drug discovery and improve patient outcomes.

Related:
GlobeNewswire Inc. favicon
GlobeNewswire Inc.www.globenewswire.com

Law firm Kahn Swick & Foti is investigating the proposed merger between Predictive Oncology and Renovaro, questioning whether the transaction adequately values the company.

Related:

1 BTC

=

- USD

Loading market data...